Rchr
J-GLOBAL ID:201801006077242950
Update date: Apr. 17, 2024
Imamura Yu
Imamura Yu
Research field (3):
Tumor diagnostics and therapeutics
, General surgery, pediatric surgery
, Digestive surgery
Research theme for competitive and other funds (29):
- 2022 - 2025 胃切除後の血糖変動を考慮した個別化栄養介入によるダンピング症候群の克服
- 2022 - 2025 食道癌手術後の呼吸器合併症減少を目指した革新的リスク評価法の確立
- 2021 - 2024 革新的治療法開発を目指した食道胃接合部腺癌の網羅的ゲノム解析
- 2020 - 2023 AIを用いたCTテクスチャ解析による大腸癌肝転移に対する化学療法の治療効果予測
- 2019 - 2023 肥満合併食道癌における癌細胞-脂肪細胞間相互作用の解明と新規治療法の開発
- 2020 - 2023 新規免疫治療創出を目指したMSI-low上部消化管腺癌の網羅的免疫・ゲノム解析
- 2019 - 2022 Molecular mechanism and novel target of diffuse histological type of non-EBV/non-MSI-H esophagogastric junction adenocarcinoma
- 2019 - 2022 Comprehensive analyses of the importance of mean corpuscular volume to estimate short-term and long-term outcomes in patients with esophageal squamous cell carcinoma who undergo esophagectomy
- 2019 - 2022 Detection of lymph node micrometastasis in rectal cancer
- 2019 - 2021 低レベルマイクロサテライト不安定性の発癌機構の解明と免疫治療バイオマーカーの創出
- 2020 - 2021 上部消化管腺癌におけるMSI-lowに着目した網羅的免疫・ゲノム解析による新規免疫治療創出
- 2018 - 2021 Identification of molecular mechanism underlying inflammatory-related carcinogenesis through activating the stroma in gastric cancer
- 2018 - 2021 Fusobacterium nucleatum Confers Chemoresistance by Modulating Autophagy in Esophageal Squamous Cell Carcinoma
- 2018 - 2020 Comprehensive analysis of gut microbiome and sarcopenia in gastrointestinal cancers
- 2017 - 2020 To identify the molecular mechanism underlying colorectal cancer progression via RNF43
- 2016 - 2019 Comprehensive analysis for the association between microbiome in the gastric mucosa and malignant potential of gastric cancer
- 2015 - 2018 Comprehensive analysis to elucidate the mechanism of cancer metabolism in esophageal squamous cell carcinoma
- 2015 - 2018 Global genomic analysis of the stromal compartments of the esophagus toward the establishment of novel treatment for esophageal cancer.
- 2017 - 2018 メチル化異常の網羅的解析による食道胃接合部腺癌の新たな分類と治療標的分子の探索
- 2016 - 2018 食道胃接合部腺癌におけるKRAS遺伝子増幅の意義とその悪性化メカニズムの解明
- 2014 - 2017 Visceral obesity impacts on adipokine expression and cancer recurrence in patients with colorectal cancer
- 2014 - 2017 The identification of novel microRNAs regulating cancer stem cell properties and the clinical application to therapeutic strategy in gastrointestinal cancer
- 2015 - 2016 消化管癌の新規バイオマーカー開発をめざしたDNA脱メチル化関連酵素の網羅的解析
- 2013 - 2016 Tumor-suppressive effects and mechanism of a novel PPAR gamma agonist in esophageal caner
- 2013 - 2016 Comprehensive analysis of expression and function of lincRNA in gastroenterological cancer
- 2016 - 食道胃接合部腺癌おける遺伝子増幅異常を標的とした新規治療法の開発
- 2013 - 2015 FGFR2を標的とした食道胃接合部癌に対する新規治療法の確立
- 2013 - 食道胃接合部癌に対するFGFR2を標的とした新規治療戦略の確立
- 2013 - 食道胃接合部癌に対するFGFR標的治療法の確立
Show all
Papers (454):
-
Naoya Yoshida, Kojiro Eto, Takashi Matsumoto, Keisuke Kosumi, Yu Imamura, Masaaki Iwatsuki, Yoshifumi Baba, Yuji Miyamoto, Masayuki Watanabe, Hideo Baba. Omental Flap Wrapping around the Esophagogastric Anastomosis and Association with Anastomotic Leak in Esophagectomy for Esophageal Cancer: A Propensity Score-Matching Analysis. Journal of the American College of Surgeons. 2022. 236. 1. 189-197
-
今村 裕, 渡邊 雅之, 蟹江 恭和, 栗山 健吾, 丸山 傑, 坂本 啓, 岡村 明彦, 金森 淳, 布部 創也, 吉田 直矢, et al. 食道胃接合部がんの集学的治療のこれから 分子生物学的特徴に基づいた食道胃接合部癌の新たな治療戦略. 日本癌治療学会学術集会抄録集. 2022. 60回. OWS16-3
-
蟹江 恭和, 岡村 明彦, 大竹 玲子, 藤原 彩, 松尾 宏美, 金森 淳, 今村 裕, 熊谷 厚志, 渡邊 雅之. 食道癌周術期栄養管理をめぐる最新の話題 適切な栄養瘻造設の経路と長期的な栄養瘻依存のリスク因子解析. 日本食道学会学術集会プログラム・抄録集. 2022. 76回. 45-45
-
Suguru Maruyama, Akihiko Okamura, Yasukazu Kanie, Kei Sakamoto, Daisuke Fujiwara, Jun Kanamori, Yu Imamura, Koshi Kumagai, Masayuki Watanabe. C-reactive protein to prealbumin ratio: a useful inflammatory and nutritional index for predicting prognosis after curative resection in esophageal squamous cell carcinoma patients. Langenbeck's archives of surgery. 2022. 407. 5. 1901-1909
-
Naoya Yoshida, Tomo Horinouchi, Kojiro Eto, Kazuto Harada, Hiroshi Sawayama, Yu Imamura, Masaaki Iwatsuki, Takatsugu Ishimoto, Yoshifumi Baba, Yuji Miyamoto, et al. Prognostic Value of Pretreatment Red Blood Cell Distribution Width in Patients With Esophageal Cancer Who Underwent Esophagectomy: A Retrospective Study. Annals of surgery open : perspectives of surgical history, education, and clinical approaches. 2022. 3. 2. e153
more...
MISC (222):
-
速水 克, 渡邊 雅之, 峯 真司, 今村 裕, 岡村 明彦, 湯田 匡美, 山下 公太郎, 庄司 佳晃, 石塚 直樹, 布部 創也. エネルギ-デバイスの把持範囲に基づいた、デバイス温度と側方熱進展についての検討. 日本消化器外科学会総会. 2021. 76回. P244-2
-
Yu Imamura, Keisho Chin, Takahiro Tsushima, Yasuhiro Tsubosa, Hiroki Hara, Takashi Fukuda, Motoo Nomura, Shigeru Tsunoda, Takashi Ogata, Tsutomu Hayashi, et al. Phase II study of systemic chemotherapy with S-1 plus oxaliplatin followed by surgery in patients with cT3-T4a and/or node-positive advanced adenocarcinoma of the esophagogastric junction: Primary endpoint results of the ESOX trial. JOURNAL OF CLINICAL ONCOLOGY. 2021. 39. 3
-
Yu Imamura, Tasuku Toihata, Manabu Takamatsu, Norio Tanaka, Shinji Mine, Seiichi Mori, Eiji Oki, Masaru Morita, Hideo Baba, Takeshi Sano, et al. MSI-low is an intermediate type between MSI-high and MSS in esophagogastric junction adenocarcinoma. JOURNAL OF CLINICAL ONCOLOGY. 2019. 37. 4
-
Yu Imamura, Shinji Mine, Naoki Hiki, Eiji Oki, Manabu Yamamoto, Masaru Morita, Yoshihiko Maehara, Hideo Baba, Takeshi Sano, Masayuki Watanabe. Molecular Status Changes According to Tumor Location in EGJ Adenocarcinoma Abstracts. DIGESTION. 2019. 99. 1. 100-101
-
岡村明彦, 渡邊雅之, 井田智, 安福至, 庄司佳晃, 山下公太郎, 速水克, 今村裕, 熊谷厚志, 布部創也, et al. 上部消化管外科における周術期感染症対策-High volume centerでの取り組み-. 日本外科感染症学会雑誌. 2017. 14. 5. 487-487
more...
Lectures and oral presentations (42):
-
Molecular subtypeと食道浸潤長からみた食道胃接合部腺癌の至適リンパ節郭清範囲
(The 121st Annual Congress of Japan Surgical Society 2021)
-
Features of esophagogatric junction adenocarcinoma with intramural esophageal invasion.
(The 93rd Annual Meeting of the Japanese Society of Gastric Cancer Association 2021)
-
Phase II study of systemic chemotherapy with S-1 plus oxaliplatin followed by surgery in patients with cT3-T4a and/or node-positive advanced adenocarcinoma of the esophagogastric junction: Primary endpoint results of the ESOX trial.
(Gastrointestinal Cancers Symposium (ASCO-GI 2021) 2021)
-
Examining #16 and #101/106rec nodes as regional lymph nodes to be dissected for EGJ adenocarcinoma.
(The 75th General Meeting of the Japanese Society of Gastroenterological Surgery 2020)
-
Molecular subtypeによる食道胃接合部腺癌の至適リンパ節郭清範囲
(The 74th Annual Meeting of the Japan Esophageal Society 2020)
more...
Education (2):
- 2006 - 2010 Kumamoto University
- 1996 - 2002 Kumamoto University School of Medicine School of Medicine
Work history (8):
- 2019/06 - 現在 がん研有明病院 消化器センター 食道外科 医長
- 2017/05 - 2019/05 がん研有明病院 消化器センター 食道外科 副医長
- 2015/04 - 2017/04 がん研有明病院 消化器センター 食道外科 医員
- 2014/04 - 2015/03 Kyushu University
- 2013/06 - 2014/03 Kumamoto University University Hospital
- 2013/05 - 2013/06 Kumamoto University University Hospital
- 2010/12 - 2013/04 Dana-Farber Cancer Institute/Harvard Cancer Center Department of Medical Oncology Research Fellow
- 2010/04 - 2010/11 Kumamoto University University Hospital
Show all
Committee career (3):
- 2021/07 - 現在 日本食道学会 評議員
- 2020/05 - 現在 日本消化器外科学会 評議員
- 2013 - 現在 日本胃癌学会 代議員
Awards (7):
Association Membership(s) (12):
American College of Surgeons
, American Society of Clinical Oncology
, 日本癌学会
, 日本消化器病学会
, 日本胸部外科学会
, 日本食道学会
, 日本胃癌学会
, 日本内視鏡外科学会
, 日本癌治療学会
, 日本消化器外科学会
, 日本外科学会
, 日本気管食道学会
Return to Previous Page